Table 1.
Characteristic | Overall | Not reclassified (SBP 120–129) | Reclassified to stage 1 hypertension (SBP 130–139) | Reclassified to stage 2 hypertension (SBP 140–159) |
---|---|---|---|---|
N | 2193 | 658 | 648 | 887 |
Age (years), mean (SD) | 79.2 (4.6) | 78.8 (4.5) | 79.2 '4.5) | 79.6 (4.7) |
Age category (years) | ||||
71–75 | 557 (25.4%) | 196 (29.8%) | 153 (23.6%) | 208 (23.4%) |
76–85 | 1383 (63.1%) | 394 (59.9%) | 426 (65.7%) | 563 (63.5%) |
86–95 | 253 (11.5%) | 68 (10.3%) | 69 (10.6%) | 116 (13.1%) |
Sex | ||||
Female | 1286 (58.6%) | 351 (53.3%) | 374 (57.7%) | 561 (63.2%) |
Male | 907 (41.4%) | 307 (46.7%) | 274 (42.3%) | 326 (36.8%) |
Race | ||||
Black | 553 (25.2%) | 168 (25.5%) | 153 (23.6%) | 232 (26.2%) |
White | 1640 (74.8%) | 490 (74.5%) | 495 (76.4%) | 655 (73.8%) |
Education | ||||
Less than high school | 267 (12.2%) | 79 (12.0%) | 66 (10.2%) | 122 (13.8%) |
High school or some college | 875 (40.0%) | 252 (38.4%) | 268 (41.4%) | 355 (40.2%) |
College graduate | 1046 (47.8%) | 326 (49.6%) | 313 (48.4%) | 407 (46.0%) |
Household income | ||||
<$25,000 | 499 (25.0%) | 160 (26.5%) | 144 (24.0%) | 195 (24.7%) |
$25,000-$74,999 | 1036 (52.0%) | 303 (50.2%) | 305 (50.7%) | 428 (54.2%) |
$75,000+ | 459 (23.0%) | 140 (23.2%) | 152 (25.3%) | 167 (21.1%) |
History of CVD | 373 (17.0%) | 107 (16.3%) | 104 (16.0%) | 162 (18.3%) |
History of Diabetes | 704 (32.8%) | 218 (33.8%) | 183 (28.7%) | 304 (35.1%) |
Current smoking | 148 (6.9%) | 45 (7.0%) | 44 (6.9%) | 59 (6.8%) |
Number of medications, | 9.0 (4.7) | 9.1 (4.8) | 9.0 (4.7) | 9.0 (4.5) |
mean (SD) | ||||
Hypertension treatment | 1677 (76.9%) | 486 (74.7%) | 500 (77.4%) | 691 (78.2%) |
Total Cholesterol (mg/dL), mean (SD) | 174.8 (39.1) | 172.8 (40.1) | 172.9 (37.4) | 177.7 (39.4) |
HDL-C Cholesterol (mg/dL), mean (SD) | 52.7 (14.1) | 52.2 (14.0) | 52.2 (13.8) | 53.4 (14.3) |
eGFR (mL/min/1.73m2) | ||||
<30 | 59 (2.8%) | 20 (3.1%) | 16 (2.6%) | 23 (2.7%) |
30–59 | 793 (37.5%) | 215 (33.8%) | 233 (37.2%) | 345 (40.5%) |
60–89 | 1131 (53.5%) | 358 (56.3%) | 345 (55.1%) | 428 (50.3%) |
90+ | 130 (6.2%) | 43 (6.8%) | 32 (5.1%) | 55 (6.5%) |
Sport/exercise composite score,a mean (SD) | 2.6 (0.8) | 2.6 (0.8) | 2.6 (0.8) | 2.6 (0.8) |
SPPB score,b mean (SD) | 9.2 (2.6) | 9.1 (2.6) | 9.3 (2.6) | 9.1 (2.7) |
Chair stand,b mean (SD) | 2.2 (1.3) | 2.1 (1.3) | 2.3 (1.3) | 2.1 (1.3) |
Summary balance score,b mean (SD) | 3.4 (1.1) | 3.4 (1.1) | 3.5 (1.1) | 3.4 (1.2) |
4 meter walk score,b mean (SD) | 3.6 (0.8) | 3.6 (0.8) | 3.6 (0.8) | 3.5 (0.8) |
Grip strength (kg), mean (SD) | 25.9 (13.8) | 17.3 (13.3) | 35.6 (14.9) | 21.3 (4.2) |
MMSE score,c mean (SD) | 27.8 (2.8) | 27.8 (3.0) | 27.9 (2.7) | 27.8 (2.6) |
Dementia | 115 (5.3% ) | 41 (6.2%) | 34 (5.3%) | 40 (4.6%) |
Moderate to severe hearing loss | 562 (27.2%) | 155 (25.4%) | 166 (26.8%) | 241 (28.9%) |
CES-Depression scale,d mean (SD) | 2.5 (2.6) | 2.5 (2.7) | 2.5 (2.6) | 2.5 (2.6) |
Composite score ranging from 1 to 5 integrating intensity of and time spent exercising or playing sports during leisure time
Short physical performance battery score integrates three components scored 0 to 4 with a total score ranging from 0 to 12
Mini mental status examination score ranging from 0 to 30
Clinical Epidemiology Studies 11-item Depression scale ranging from 0 to 22
Data presented are N (%) unless otherwise specified. CVD: cardiovascular disease; SBP: systolic blood pressure; eGFR: estimated glomerular filtration rate